Literature DB >> 9784156

Isolation, structure determination, and biological activity of dolastatin 12 and lyngbyastatin 1 from Lyngbya majuscula/Schizothrix calcicola cyanobacterial assemblages.

G G Harrigan1, W Y Yoshida, R E Moore, D G Nagle, P U Park, J Biggs, V J Paul, S L Mooberry, T H Corbett, F A Valeriote.   

Abstract

Lyngbyastatin 1 (1a), a new cytotoxic analogue of dolastatins 12 (2a) and 11 (4), was isolated as an inseparable mixture with its C-15 epimer (1b) from extracts of a Lyngbya majuscula/Schizothrix calcicola assemblage and a L. majuscula strain collected near Guam. Dolastatin 12 (2a) was also encountered as an inseparable mixture with its C-15 epimer (2b) in L. majuscula/S. calcicola assemblages. At least one of the compounds in each mixture appeared to exist in solution as a mixture of slowly interconverting conformers resulting in broadened signals in 1H NMR spectra. Structure elucidation therefore relied principally on mass spectroscopy and chemical degradation studies. Both 1ab and 2ab proved toxic with only marginal or no antitumor activity when tested against colon adenocarcinoma #38 or mammary adenocarcinoma #16/C. Both 1ab and 2ab were shown to be potent disrupters of cellular microfilament networks.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9784156     DOI: 10.1021/np9801211

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  22 in total

1.  Natural products chemistry and taxonomy of the marine cyanobacterium Blennothrix cantharidosmum.

Authors:  Benjamin R Clark; Niclas Engene; Margaret E Teasdale; David C Rowley; Teatulohi Matainaho; Frederick A Valeriote; William H Gerwick
Journal:  J Nat Prod       Date:  2008-08-13       Impact factor: 4.050

Review 2.  Biological targets and mechanisms of action of natural products from marine cyanobacteria.

Authors:  Lilibeth A Salvador-Reyes; Hendrik Luesch
Journal:  Nat Prod Rep       Date:  2015-03       Impact factor: 13.423

Review 3.  Marine Mollusk-Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance.

Authors:  Maria Letizia Ciavatta; Florence Lefranc; Marianna Carbone; Ernesto Mollo; Margherita Gavagnin; Tania Betancourt; Ramesh Dasari; Alexander Kornienko; Robert Kiss
Journal:  Med Res Rev       Date:  2016-12-07       Impact factor: 12.944

Review 4.  Bioactive Compounds from Marine Heterobranchs.

Authors:  Conxita Avila; Carlos Angulo-Preckler
Journal:  Mar Drugs       Date:  2020-12-21       Impact factor: 5.118

5.  Veraguamides A-G, cyclic hexadepsipeptides from a dolastatin 16-producing cyanobacterium Symploca cf. hydnoides from Guam.

Authors:  Lilibeth A Salvador; Jason S Biggs; Valerie J Paul; Hendrik Luesch
Journal:  J Nat Prod       Date:  2011-03-29       Impact factor: 4.050

6.  A Complementary Chemical and Genomic Screening Approach for Druggable Targets in the Nrf2 Pathway and Small Molecule Inhibitors to Overcome Cancer Cell Drug Resistance.

Authors:  James H Matthews; Xiao Liang; Valerie J Paul; Hendrik Luesch
Journal:  ACS Chem Biol       Date:  2018-03-22       Impact factor: 5.100

Review 7.  Marine natural product peptides with therapeutic potential: Chemistry, biosynthesis, and pharmacology.

Authors:  Vedanjali Gogineni; Mark T Hamann
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-08-24       Impact factor: 3.770

8.  Antineoplastic agents. 590. X-ray crystal structure of dolastatin 16 and syntheses of the dolamethylleuine and dolaphenvaline units.

Authors:  George R Pettit; Thomas H Smith; Jun-Ping Xu; Delbert L Herald; Erik J Flahive; Collin R Anderson; Paul E Belcher; John C Knight
Journal:  J Nat Prod       Date:  2011-05-03       Impact factor: 4.050

9.  Quantitative molecular networking to profile marine cyanobacterial metabolomes.

Authors:  Jacob R Winnikoff; Evgenia Glukhov; Jeramie Watrous; Pieter C Dorrestein; William H Gerwick
Journal:  J Antibiot (Tokyo)       Date:  2013-11-27       Impact factor: 2.649

10.  Desmethoxymajusculamide C, a cyanobacterial depsipeptide with potent cytotoxicity in both cyclic and ring-opened forms.

Authors:  T Luke Simmons; Lisa M Nogle; Joseph Media; Frederick A Valeriote; Susan L Mooberry; William H Gerwick
Journal:  J Nat Prod       Date:  2009-06       Impact factor: 4.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.